Haemonetics Corporation (HAE)

Haemonetics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year Ending	Current	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021	Mar 28, 2020
Market Capitalization	4,563	4,335	4,175	3,263	5,694	5,078
Market Cap Growth	3.83%	3.83%	27.92%	-42.69%	12.14%	13.79%
Enterprise Value	5,150	4,964	4,656	3,778	6,209	5,323
PE Ratio	38.75	36.87	36.17	75.24	71.65	66.35
PS Ratio	3.45	3.31	3.57	3.29	6.54	5.14
PB Ratio	4.71	4.51	5.10	4.36	7.78	8.65
P/FCF Ratio	38.55	36.96	25.38	41.96	77.39	40.22
P/OCF Ratio	24.88	23.85	15.29	18.94	52.33	32.09
EV/Sales Ratio	3.93	3.79	3.98	3.80	7.13	5.38
EV/EBITDA Ratio	19.65	18.94	18.67	21.16	35.68	24.91
EV/EBIT Ratio	31.23	30.10	29.84	46.78	69.19	51.50
EV/FCF Ratio	43.92	42.33	28.31	48.57	84.39	42.17
Debt / Equity Ratio	0.84	0.84	0.94	1.03	0.97	0.65
Debt / EBITDA Ratio	3.08	3.08	3.07	4.33	4.07	1.79
Debt / FCF Ratio	6.89	6.89	4.66	9.95	9.62	3.03
Quick Ratio	1.28	1.28	1.84	0.95	1.26	1.10
Current Ratio	2.56	2.56	3.06	1.71	2.74	2.20
Asset Turnover	0.63	0.63	0.62	0.55	0.58	0.80
Interest Coverage	12.67	12.67	10.67	4.72	5.33	6.38
Return on Equity (ROE)	12.80%	12.80%	14.90%	6.10%	11.70%	13.10%
Return on Assets (ROA)	5.60%	5.60%	6.20%	2.40%	5.30%	6.20%
Return on Capital (ROIC)	7.22%	7.22%	8.04%	3.61%	6.80%	9.36%
Earnings Yield	2.60%	2.71%	2.76%	1.33%	1.40%	1.51%
FCF Yield	2.59%	2.71%	3.94%	2.38%	1.29%	2.49%
Buyback Yield / Dilution	0.04%	0.04%	-0.13%	-0.12%	1.01%	2.13%
Total Shareholder Return	0.04%	0.04%	-0.13%	-0.12%	1.01%	2.13%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).